Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Hedin Andrew — Kymera Therapeutics, Inc. insider: 1 transactions · InsiderLens

Feed Screener Search Methodology

Pricing Sign in

Home / Insiders / Hedin Andrew

Hedin Andrew

Director at Kymera Therapeutics, Inc. · on record since Aug 21, 2020

Insider trading activity of Hedin Andrew

Transactions on record: 1; since Aug 21, 2020

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 21, 2020

Figures computed from official regulatory filings — methodology.

Companies where Hedin Andrew has traded

Kymera Therapeutics, Inc.1 tx · Aug 21, 2020

Track record of Hedin Andrew

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hedin Andrew

Co-insiders of Hedin Andrew

667, L.P.Kymera Therapeutics, Inc.
Adams BrianKymera Therapeutics, Inc.
Albers Jeffrey W.Kymera Therapeutics, Inc.
Alexandria Venture Investments, LLCKymera Therapeutics, Inc.
Atlas Venture Associates Opportunity I, LLCKymera Therapeutics, Inc.
Atlas Venture Associates Opportunity I, L.P.Kymera Therapeutics, Inc.
Atlas Venture Associates X, LLCKymera Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

ATLAS VENTURE ASSOCIATES X, L.P.Kymera Therapeutics, Inc.

Atlas Venture Fund X, L.P.Kymera Therapeutics, Inc.

Atlas Venture Opportunity Fund I, L.P.Kymera Therapeutics, Inc.

Baker Bros. Advisors (GP) LLCKymera Therapeutics, Inc.

BAKER BROS. ADVISORS LPKymera Therapeutics, Inc.

Baker Brothers Life Sciences LPKymera Therapeutics, Inc.

BAKER FELIXKymera Therapeutics, Inc.

BAKER JULIANKymera Therapeutics, Inc.

BIOTECHNOLOGY VALUE FUND II LPKymera Therapeutics, Inc.

BIOTECHNOLOGY VALUE FUND L PKymera Therapeutics, Inc.

Biotechnology Value Trading Fund OS LPKymera Therapeutics, Inc.

Booth BruceKymera Therapeutics, Inc.

BVF GP HOLDINGS LLCKymera Therapeutics, Inc.

BVF I GP LLCKymera Therapeutics, Inc.

BVF II GP LLCKymera Therapeutics, Inc.

BVF INC/ILKymera Therapeutics, Inc.

BVF PARTNERS L P/ILKymera Therapeutics, Inc.

BVF Partners OS Ltd.Kymera Therapeutics, Inc.

Caughey ElaineKymera Therapeutics, Inc.

Chadwick Jeremy GKymera Therapeutics, Inc.

Chesworth RichardKymera Therapeutics, Inc.

Chiniara EllenKymera Therapeutics, Inc.

Esposito PamelaKymera Therapeutics, Inc.

Gollob JaredKymera Therapeutics, Inc.

Goodman NoahKymera Therapeutics, Inc.

Green JeremyKymera Therapeutics, Inc.

Hall Steven EdwardKymera Therapeutics, Inc.

Horobin JoannaKymera Therapeutics, Inc.

Hrustanovic GorjanKymera Therapeutics, Inc.

Jacobs Bruce N.Kymera Therapeutics, Inc.

LAMPERT MARK NKymera Therapeutics, Inc.

Mainolfi NelloKymera Therapeutics, Inc.

MARAGANORE JOHNKymera Therapeutics, Inc.

Morgan LeighKymera Therapeutics, Inc.

Nicholson Donald WilliamKymera Therapeutics, Inc.

Redmile Group, LLCKymera Therapeutics, Inc.

Ridloff ElenaKymera Therapeutics, Inc.

Sandor VictorKymera Therapeutics, Inc.

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Kymera Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Kymera Therapeutics, Inc.	Aug 21, 2020	AwardD	40,127	0.00 USD	$0	SEC